2025 annual financial data
Amphastar Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was 19.5%.
Operating income was 140,403,000 USD and net income was 98,094,000 USD.
Operating cash flow was 156,115,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 719,887,000 USD
- Operating income
- 140,403,000 USD
- Net income
- 98,094,000 USD
- Operating cash flow
- 156,115,000 USD